Advanced Strategies for Accelerating Early Detection
Accelerating Breakthroughs in Alzheimer's & Early Detection
Advising emerging diagnostics and therapeutic companies to navigate strategy, clinical pathways and successful market entry
Accelerating Breakthroughs in Alzheimer's & Early Detection
Advising emerging diagnostics and therapeutic companies to navigate strategy, clinical pathways and successful market entry
The Neurodegenerative Disease Trial Crisis
Neurodegenerative disease trials are facing a crisis. From Alzheimer's and Parkinson's to ALS and Multiple Sclerosis, recruitment timelines are stretching longer, costs are skyrocketing, and promising treatments are being delayed or abandoned. Traditional approaches to trial recruitment are falling short across the neurology space, leaving pharmaceutical companies frustrated and patients waiting for breakthroughs.
The True Cost of Delayed Recruitment
Every day your neurodegenerative disease trial falls behind schedule, you're losing $30,000 to $100,000. But it's not just about money.
Each delay means:
Competitors could beat you to market in a rapidly evolving field
Investors lose confidence in your program
Most importantly, patients suffering from debilitating neurological conditions lose hope
The average neurodegenerative disease trial takes 18-24 months just to recruit patients.
Can your company afford that kind of delay in this competitive landscape? Can patients with progressive conditions wait that long?
Problem Agitation
The True Cost of Delayed Recruitment
Every day your neurodegenerative disease trial falls behind schedule, you're losing $30,000 to $100,000. But it's not just about money.
Each delay means:
Competitors could beat you to market in a rapidly evolving field
Investors lose confidence in your program
Most importantly, patients suffering from debilitating neurological conditions lose hope
The average neurodegenerative disease trial takes 18-24 months just to recruit patients.
Can your company afford that kind of delay in this competitive landscape? Can patients with progressive conditions wait that long?
Traditional Fixes That Don’t Get it Done
Leaning too hard on your clinical operations team?
While excellent at managing protocols and procedures, Clin Ops teams are often overwhelmed with multiple responsibilities. They approach recruitment with an operational mindset, focusing on processes rather than building the deep, trust-based relationships crucial for neurodegenerative disease trials.
Patient recruitment companies?
They apply one-size-fits-all strategies like SEO and software based solutions that ignore the unique challenges of neurodegenerative disease trials. They lack the scientific depth to effectively communicate with investigators and potential participants about complex neurological concepts.
Digital
advertising?
It's a drop in the bucket for neurodegenerative conditions, especially those affecting older populations who may not be as responsive to online outreach.
Site Engagement Liasons from CRO's?
An expensive option that has little to no impact. While they do focus on site relationships, they lack the scientific depth to connect with neurology experts. Their engagement misses the opportunity to tap into the investigator's scientific curiosity and motivation.
Leaning too hard on your clinical operations team?
While excellent at managing protocols and procedures, Clin Ops teams are often overwhelmed with multiple responsibilities. They approach recruitment with an operational mindset, focusing on processes rather than building the deep, trust-based relationships crucial for neurodegenerative disease trials
Digital
advertising?
It's a drop in the bucket for neurodegenerative conditions, especially those affecting older populations who may not be as responsive to online outreach.
The Elevated Clinical Difference
Elevated Clinical offers a unique blend of deep scientific knowledge and exceptional relationship-building skills:
Translating Science Into Strategy
With a neuroscience Ph.D. at the helm, we guide Alzheimer’s innovators to connect research breakthroughs with real-world impact—bridging the gap between discovery, validation, and adoption.
Relationships That Drive Results
Our deep network of Alzheimer’s experts, investigators, and key opinion leaders enables meaningful collaborations that advance promising diagnostic and therapeutic innovations.
Tailored Strategies for Growth
Every Alzheimer’s innovation is unique. We design strategic roadmaps that align scientific promise with the right clinical, regulatory, and market pathways for sustainable success.
Turning Science Into a Story That Moves People
We craft compelling scientific narratives that build credibility, attract collaborators, and position Alzheimer’s innovators for meaningful visibility and impact.
Proven Track
Record
We've helped our clients peek around corners and equipped them to address hurdles that have left other promising start-ups dead on arrival.
Enhancing What Works. Elevating What’s Next.
We enhance your existing trial management efforts, providing specialized recruitment acceleration without disrupting your processes.
Winnie Pak, PhD
Head of Strategy
With more than two decades in pharmaceutical leadership, Dr. Winnie Pak specializes in helping emerging Alzheimer’s diagnostic and therapeutic companies bridge science, strategy, and execution.
She combines a deep understanding of neurodegenerative disease with hands-on experience leading global medical affairs, building MSL teams, and guiding programs toward clinical and commercial readiness.
Winnie’s extensive network of thought leaders and investigators across the Alzheimer’s community amplifies her ability to align science with strategy—empowering her clients to move faster, smarter, and with greater confidence.
Testimonials
I worked with Dr. Pak in aiding drug development from my role as a site PI. Her enthusiasm, knowledge of clinical trials, hurdles and pitfalls helped our site get started up quickly, enroll, and overcome challenges. Dr. Pak's analysis, anticipation of problems helped us complete this trial. Her collaborative approach combined with her expertise helped us go from start up to last subject last visit with a minimum of deviations and stress. Dr. Pak is always available, always helpful, clear headed and focused.
David Weisman,
MD, Founder, Clinical Trial Center, Abington Neurological Associates
I had the pleasure of working with Winnie for several years at biotech company focused on rare disease therapeutics. She has a great understanding of clinical development and operations but her true “super power” is her ability to get different functions, sometimes with opposing priorities to work together and focus on the higher objective. One of several examples I can give is when she rallied several functions, including our MSL team, working on the pivotal study in a super orphan indication that was struggling to enroll. Her efforts lead to shaving over a year from our predicted enrollment time with no hit to data quality
Julio Gagne,
Vice President, Program & Alliance Management, Travere Therapeutics
Winnie's help was instrumental in our site's success in reaching our enrollment targets. Her suggestions, experience with recruitment strategies, and overall knowledge of the protocol and data enabled our site team to act in a proactive and thoughtful way to approach participant recruitment and selection. Winnie's desire to understand how our site works, our individual challenges and types of resources allowed her to help us create a customized and unique recruitment plan to meet and exceed our participant targets. She is a pleasure to work with and genuinely wants sites to be successful.
Elitza Hristova,
Director of Regulatory Affairs/Business Development Lead, Ottawa Memory Clinic
I’ve had the pleasure of collaborating closely with Dr. Winnie Pak, and I can’t speak highly enough of her impact on clinical trial recruitment. Winnie’s deep expertise in neurology and her remarkable knack for connecting with clinical trial sites have sped up the enrollment process by six months in her previous role with Pharma. Her relationship-driven approach and wide network of thought leaders have been incredibly valuable to our projects. Winnie’s strategic insights and unwavering commitment to improving clinical trials make her an indispensable partner in advancing neuro research.
Dung Trinh,
MD, Founder, Clinical Trial Center, Abington Neurological Associates
I have been working with Winnie for nearly two years in the area of Alzheimer's disease and have always enjoyed my interactions with her. In this time, it is clear that she had a deep knowledge of the therapeutic area - both the supporting basic science and the clinical science - as well as an obvious passion for bringing medications to market that will improve the lives of patients. Working with Winnie was always a collaborative endeavor for which she always considered multiple perspectives and provided great feedback on tactical ideas. I think anyone in the process of developing a medication, device, or diagnostic test for a neurodegenerative disease would find great benefit in working with Winnie.
Senior Clinical Strategy Director, Medscape Education
I have worked with Dr Winnie Pak as a consultant on a number of medical affairs and clinical development/operations projects. She is a dedicated, hardworking scientist who is also business and drug development savvy. Her broad range of experience and neuroscience acumen have made all my collaborations with her highly productive and efficient. I am always excited to get a call from her.
Shawn Hayes,
PhD, Founder, Lark Scientific Research
I had the pleasure of working with Winnie for several years on a rare disease clinical development program at a biotech company. Winnie possesses a deep understanding of clinical development and the related operations, complemented by exceptional program management skills. She excels at bringing together different functions, enabling effective collaboration toward shared objectives. Her highly structured and organized approach significantly contributed to the success of our study, particularly in the areas of patient enrollment and retention. Winnie was one of the most reliable and motivated contributors to our team.
Feriandas Greblikas,
MD, Executive Director, Dianthus Therapeutic
I have had the pleasure to collaborate with Winnie over the past 2 years regarding educational programs in the area of neurology. She is knowledgeable, creative, resourceful and a pleasure to work with.
Kelly Hanley,
Senior Director, Medscape Education
Testimonials
I worked with Dr. Pak in aiding drug development from my role as a site PI. Her enthusiasm, knowledge of clinical trials, hurdles and pitfalls helped our site get started up quickly, enroll, and overcome challenges. Dr. Pak's analysis and anticipation of problems helped us complete this trial. Her collaborative approach combined with her expertise helped us go from start up to last subject last visit with a minimum of deviations and stress. Dr. Pak is always available, always helpful, clear headed and focused.
David Weisman,
MD, Founder, Clinical Trial Center, Abington Neurological Associates
I had the pleasure of working with Winnie for several years at biotech company focused on rare disease therapeutics. She has a great understanding of clinical development and operations but her true “super power” is her ability to get different functions, sometimes with opposing priorities to work together and focus on the higher objective. One of several examples I can give is when she rallied several functions, including our MSL team, working on the pivotal study in a super orphan indication that was struggling to enroll. Her efforts lead to shaving over a year from our predicted enrollment time with no hit to data quality
Julio Gagne,
Vice President, Program & Alliance Management, Travere Therapeutics
Winnie's help was instrumental in our site's success in reaching our enrollment targets. Her suggestions, experience with recruitment strategies, and overall knowledge of the protocol and data enabled our site team to act in a proactive and thoughtful way to approach participant recruitment and selection. Winnie's desire to understand how our site works, our individual challenges and types of resources allowed her to help us create a customized and unique recruitment plan to meet and exceed our participant targets. She is a pleasure to work with and genuinely wants sites to be successful.
Elitza Hristova,
Director of Regulatory Affairs/Business Development Lead, Ottawa Memory Clinic
I’ve had the pleasure of collaborating closely with Dr. Winnie Pak, and I can’t speak highly enough of her impact on clinical trial recruitment. Winnie’s deep expertise in neurology and her remarkable knack for connecting with clinical trial sites have sped up the enrollment process by six months in her previous role with Pharma. Her relationship-driven approach and wide network of thought leaders have been incredibly valuable to our projects. Winnie’s strategic insights and unwavering commitment to improving clinical trials make her an indispensable partner in advancing neuro research.
Dung Trinh,
MD, Founder, Clinical Trial Center, Abington Neurological Associates
I have been working with Winnie for nearly two years in the area of Alzheimer's disease and have always enjoyed my interactions with her. In this time, it is clear that she had a deep knowledge of the therapeutic area - both the supporting basic science and the clinical science - as well as an obvious passion for bringing medications to market that will improve the lives of patients. Working with Winnie was always a collaborative endeavor for which she always considered multiple perspectives and provided great feedback on tactical ideas. I think anyone in the process of developing a medication, device, or diagnostic test for a neurodegenerative disease would find great benefit in working with Winnie.
Senior Clinical Strategy Director, Medscape Education
I have worked with Dr Winnie Pak as a consultant on a number of medical affairs and clinical development/operations projects. She is a dedicated, hardworking scientist who is also business and drug development savvy. Her broad range of experience and neuroscience acumen have made all my collaborations with her highly productive and efficient. I am always excited to get a call from her.
Shawn Hayes,
PhD, Founder, Lark Scientific Research
I had the pleasure of working with Winnie for several years on a rare disease clinical development program at a biotech company. Winnie possesses a deep understanding of clinical development and the related operations, complemented by exceptional program management skills. She excels at bringing together different functions, enabling effective collaboration toward shared objectives. Her highly structured and organized approach significantly contributed to the success of our study, particularly in the areas of patient enrollment and retention. Winnie was one of the most reliable and motivated contributors to our team.
Feriandas Greblikas,
MD, Executive Director, Dianthus Therapeutic
I have had the pleasure to collaborate with Winnie over the past 2 years regarding educational programs in the area of neurology. She is knowledgeable, creative, resourceful and a pleasure to work with.
Kelly Hanley,
Senior Director, Medscape Education
Working with Winnie has been a pleasure for me. Her visits to our hospital in Pamplona (Spain) to personally update me on the progress of Alzheimer’s drug research not only provided me with greater knowledge about the drug’s development and results but also demonstrated her genuine interest in each person involved in the project. Additionally, her warmth and concern for the challenges we faced impressed me from the very beginning.
Mario Riverol Fernández,
MD, Neurologist, Universidad de Navarra
Here's what our customers are saying
Testimonials
Your Paragraph text goes Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae. here
James Howie
Your Paragraph text goes Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae. here
James Howie
Your Paragraph text goes Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae. here
James Howie
Your Paragraph text goes Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae. here
James Howie
Contact Us
All Rights Reserved || Elevated Clinical
Copyright © 2024
LinkedIn